BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $117,000 | -14.0% | 78,300 | +11.1% | 0.01% | -29.4% |
Q4 2015 | $136,000 | -6.2% | 70,500 | -5.4% | 0.02% | -10.5% |
Q3 2015 | $145,000 | +262.5% | 74,500 | +276.3% | 0.02% | +216.7% |
Q2 2015 | $40,000 | -50.6% | 19,800 | -45.9% | 0.01% | -57.1% |
Q4 2014 | $81,000 | -37.7% | 36,600 | -30.7% | 0.01% | -30.0% |
Q3 2014 | $130,000 | -44.9% | 52,800 | -36.9% | 0.02% | -42.9% |
Q2 2014 | $236,000 | -11.6% | 83,700 | +91.1% | 0.04% | -16.7% |
Q1 2014 | $267,000 | +256.0% | 43,800 | +142.0% | 0.04% | +223.1% |
Q4 2013 | $75,000 | 0.0% | 18,100 | 0.0% | 0.01% | -23.5% |
Q3 2013 | $75,000 | -19.4% | 18,100 | -36.0% | 0.02% | -32.0% |
Q2 2013 | $93,000 | – | 28,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
BVF INC/IL | 435,900 | $976,000 | 0.19% |
Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |